ClinicalTrials.govpublic full text
Samuraciclib for the Treatment of Patients With Resectable, Borderline Resectable, or Locally Advanced Basal Pancreatic Cancer
resectable pancreatic ductal adenocarcinoma, borderline resectable pancreatic ductal adenocarcinoma, locally advanced pancreatic ductal adenocarcinoma, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 884408
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.